Risk Minimisation Materials

Spravato (esketamine nasal spray): Healthcare Professional Guide

This guide informs healthcare professionals about the four identified risks that may occur following Spravato treatment: transient dissociative states and perception disorders (dissociation), disturbances in consciousness (sedation), increased blood pressure and drug abuse. This guide describes the risks and explains how to minimise and manage them.

For Healthcare Professionals